-
Symbol
-
ERNA on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.005 per share
-
Latest Disclosed Ownership
-
6.21M shares
-
Security Ownership
-
9.9%
Freebird Partners LP ownership in Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)
2025-05-14 - Freebird Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.21M shares of Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA).
This represents 9.9% percent ownership of the company.
In their previous filing dated 2025-01-28, Freebird Partners LP had reported owning 5.14M shares, indicating an increase of 20.9% percent.